The DOI matches its Crossref record; 47 of the 48 references it cites were found in a registry or an index.
Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle
Open accessAbstract
The broad nature of insulin resistant glucose metabolism in skeletal muscle of patients with type 2 diabetes suggests a defect in the proximal part of the insulin signaling network. We sought to identify the pathways compromised in insulin resistance and to test the effect of moderate exercise on whole-body and cellular insulin action. We conducted euglycemic clamps and muscle biopsies on type 2 diabetic patients, obese nondiabetics and lean controls, with and without a single bout of exercise. Insulin stimulation of the phosphatidylinositol 3-kinase (PI 3-kinase) pathway, as measured by phosphorylation of the insulin receptor and IRS-1 and by IRS protein association with p85 and with PI 3-kinase, was dramatically reduced in obese nondiabetics and virtually absent in type 2 diabetic patients. Insulin stimulation of the MAP kinase pathway was normal in obese and diabetic subjects. Insulin stimulation of glucose-disposal correlated with association of p85 with IRS-1. Exercise 24 hours before the euglycemic clamp increased phosphorylation of insulin receptor and IRS-1 in obese and diabetic subjects but did not increase glucose uptake or PI 3-kinase association with IRS-1 upon insulin stimulation. Thus, insulin resistance differentially affects the PI 3-kinase and MAP kinase signaling pathways, and insulin-stimulated IRS-1-association with PI 3-kinase defines a key step in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using the euglycemic insulin clamp with skeletal muscle biopsy, a number of investigators have examined the insulin signal transduction system in human skeletal muscle of type 2 diabetic subjects and consistently demonstrated defects in IRS-1 tyrosine phosphorylation and PI-3 kinase and Akt activation ( 26 , 54 , 55 ).”
From Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes (2009) · cites this paper as [54]
Experimental — accuracy not yet measuredIn the citing paper
“In contrast, as the MAPK pathway has normal sensitivity to insulin, hyperinsulinemia activates the MAPK pathway, promoting vascular smooth muscle cell growth and activating inflammatory pathways, such as IkB/NF-kB and JNK [107,108].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [107]
In the citing paper
“Insulin resistance in skeletal muscle is manifested by decreased insulin-stimulated glucose uptake and results from impaired insulin signaling and multiple post-receptor intracellular defects including impaired glucose transport, glucose phosphorylation, and reduced glucose oxidation and glycogen synthesis.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Association of the p85 subunit of PI3K with IRS-1 and activation of PI3K also are greatly attenuated in obese nondiabetic and type 2 diabetic subjects compared with lean healthy controls [7, 165, 166].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The ability of insulin to activate insulin receptor and IRS-1 tyrosine phosphorylation in muscle in obese nondiabetic subjects is modestly reduced; whereas in type 2 diabetics insulin-stimulated insulin receptor and IRS-1 tyrosine phosphorylation are severely impaired [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Most [1, 7, 152, 153, 156, 161] but not all [155] investigators have found a reduction in tyrosine kinase activity that cannot be explained by alterations in insulin receptor number or insulin receptor binding affinity.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“In insulin-resistant obese nondiabetic subjects, in the NGT insulin resistant offspring of two diabetic parents, and in type 2 diabetic subjects, a substantial decrease in insulin receptor tyrosine phosphorylation has been demonstrated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“The decrease in insulin-stimulated association of the p85 regulatory subunit of PI3K with IRS-1 is closely correlated with the reduction in insulin-stimulated muscle glycogen synthase activity and in vivo insulin-stimulated glucose disposal [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Intact stimulation of the MAPK pathway by insulin in the presence of insulin resistance in the PI3K pathway may play an important role in the development of atherosclerosis [7].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Insulin resistance in the PI3K signaling pathway contrasts with an intact stimulation of the MAPK pathway by insulin in insulin-resistant type 2 diabetic and obese nondiabetics individuals [7, 165].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
In the citing paper
“Under basal conditions, total glycogen synthase activity in type 2 diabetic subjects is reduced, and the ability of insulin to activate glycogen synthase is severely impaired [7, 215–217].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Self-citationCheatham, B., Vlahos, C. J., Cheatham, L. A., Wang, L., Blenis, J., & Kahn, C. R. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4902-4911.1994 · Cited by 1,062
Self-citationMeasurement of Size and Turnover Rate of Body Glucose Pool by the Isotope Dilution Method
Steele, R., Wall, J. S., de Bodo, R. C., & Altszuler, N. (1956) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1956.187.1.15 · Cited by 816
Perseghin, G., Price, T. B., Petersen, K. F., Roden, M., Cline, G. W., Gerow, K., Rothman, D. L., & Shulman, G. I. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351804 · Cited by 699
Jiang, Z. Y., Lin, Y.-W., Clemont, A., Feener, E. P., Hein, K. D., Igarashi, M., Yamauchi, T., White, M. F., & King, G. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5971 · Cited by 604
Dunaif, A., Xia, J., Book, C. B., Schenker, E., & Tang, Z. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118126 · Cited by 561
Effect of physical exercise on sensitivity and responsiveness to insulin in humans
Mikines, K. J., Sonne, B., Farrell, P. A., Tronier, B., & Galbo, H. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.254.3.e248 · Cited by 538
Goodyear, L. J., Giorgino, F., Sherman, L., Carey, J., Smith, R. J., & Dohm, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117909 · Cited by 527
Ren, J., Semenkovich, C. F., Gulve, E. A., Gao, J. H., & Holloszy, J. O. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36636-x · Cited by 416
Flagged first, then by citations
1 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 9
- Cheatham, 1994, Mol Cell Biol, 14, 4902, 10.1128/MCB.14.7.4902 · DOI
- Nyomba, 1990, Am J Physiol, 258, E964
- Hayashi, 1997, Am J Physiol, 273, E1039
- Koval, 1998, Am J Physiol, 274, E304
- O’Doherty, 1994, Am J Physiol, 266, E171
- Mikines, 1988, Am J Physiol, 254, E248
- Goodyear, 1995, Am J Physiol, 268, E987
- Zorzano, 1986, Am J Physiol, 251, E664
- Kochan, 1979, Am J Physiol, 236, E660
Cited by
Sorted by citations
Items 601–700 of 997
Integrative Analyses of Genes Associated with Subcutaneous Insulin Resistance
Pujar, M. K., Vastrad, B. M., & Vastrad, C. M. (2019) · Biomolecules · doi:10.3390/biom9020037 · Cited by 24
Højlund, K., Wojtaszewski, J. F. P., Birk, J. B., Hansen, B. F., Vestergaard, H., & Beck‐Nielsen, H. (2006) · Diabetologia · doi:10.1007/s00125-006-0312-6 · Cited by 24
Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review
DeFronzo, R. A., & Auchus, R. J. (2025) · Diabetes · doi:10.2337/db25-0120 · Cited by 31
Self-citationWhy Does Obesity Increase the Risk for Cardiovascular Disease?
Boden, G. H., & Salehi, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320003 · Cited by 23
Boden, G. H., Cheung, P., Kresge, K. M., Homko, C. J., Powers, B. D., & Ferrer, L. M. (2014) · Diabetes · doi:10.2337/db14-0055 · Cited by 23
Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans
Ho, R. C., Davy, K. P., Hickey, M. S., Summers, S. A., & Melby, C. L. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00105.2002 · Cited by 23
The genetics of bipolar disorder with obesity and type 2 diabetes
Miola, A., Filippis, E. D., Veldić, M., Ho, A. M., Winham, S. J., Mendoza, M., Romo‐Nava, F., Núñez, N. A., Gardea‐Resendez, M., Prieto, M. L., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.06.084 · Cited by 26
Oh, H., Park, S. Y., Cho, W., El‐Aty, A. M. A., Hacımüftüoğlu, A., Kwon, C. H., Jeong, J. H., & Jung, T. W. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30873 · Cited by 22
Impact of Major Depressive Disorder on Prediabetes by Impairing Insulin Sensitivity
Shelton, R. C., & Li, L. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000664 · Cited by 23
Maternal chromium restriction induces insulin resistance in adult mice offspring through miRNA
Zhang, Q., Sun, X., Xiao, X., Zheng, J., Li, M., Yu, M., Ping, F., Wang, Z., Qi, C., Wang, T., et al. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3328 · Cited by 22
A Review on Molecular Mechanism of Flavonoids as Antidiabetic Agents
Jasmin, J., & Jaitak, V. (2018) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557519666181227153428 · Cited by 23
Iori, E., Millioni, R., Puricelli, L., Arrigoni, G., Lenzini, L., Trevisan, R., James, P., Rossi, G. P., Pinna, L. A., & Tessari, P. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.08.012 · Cited by 22
Miller-Scandle, T., & McGee, D. W. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01352.x · Cited by 22
Venugopal, J., Hanashiro, K., Yang, Z., & Nagamine, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405278101 · Cited by 22
Regulation of Intermediary Metabolism During Fasting and Feeding
DeFronzo, R. A., & Ferrannini, E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00035-4 · Cited by 22
Self-citationBlanks, A. M., Rodriguez‐Miguelez, P., Looney, J. C., Tucker, M. A., Jeong, J., Thomas, J., Blackburn, M., Stepp, D. W., Weintraub, N. J., & Harris, R. A. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100011 · Cited by 21
Rampin, A., Carrabba, M., Mutoli, M., Eman, C. L., Testa, G., Madeddu, P. R., & Spinetti, G. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0134 · Cited by 24
Tissue Oxygen Demand in Regulation of the Behavior of the Cells in the Vasculature
Barvitenko, N. N., Aslam, M., Filosa, J. A., Matteucci, E., Nikinmaa, M., Pantaleo, A., Saldanha, C., & Baskurt, O. K. (2013) · Microcirculation · doi:10.1111/micc.12052 · Cited by 21
Effect of L-carnitine on diabetes-induced changes of skeletal muscles in rats
Samir, S. M., Abbas, A. M., Safwat, S. M., & Elserougy, H. G. (2017) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2016-0185 · Cited by 21
Kashyap, S. R., Belfort, R., Cersósimo, E., Lee, S., & Cusi, K. J. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00013.x · Cited by 21
Self-citationInvolvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation
Li, F., Xia, K., Sheikh, M. S. A., Cheng, J., Li, C., & Yang, T. (2014) · Endocrine · doi:10.1007/s12020-014-0304-0 · Cited by 21
Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors
Boden, G. H., Song, W., Kresge, K. M., Mozzoli, M. A., & Cheung, P. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90370.2008 · Cited by 21
Ishizawa, K., Yoshizumi, M., Tsuchiya, K., Takishita, E., Nakaya, Y., Kishi, K., Ebina, Y., Houchi, H., Minakuchi, K., & Tamaki, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01405-4 · Cited by 21
The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro
Verma, N. K., & Dey, C. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0260-1 · Cited by 21
Lefai, É., Roques, M., Véga, N., Laville, M., & Vidal, H. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3600117 · Cited by 20
Basal Insulin: Beyond Glycemia
Niswender, K. D. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.07.2301 · Cited by 20
The cardiovascular effects of insulin
Younk, L. M., Lamos, E. M., & Davis, S. N. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.919256 · Cited by 20
Cell‐specific insulin resistance: implications for atherosclerosis
Rajwani, A., Cubbon, R. M., & Wheatcroft, S. B. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2336 · Cited by 20
Lipid-Induced Insulin Resistance in the Liver
Katsanos, C. S. (2004) · Sports Medicine · doi:10.2165/00007256-200434140-00002 · Cited by 21
Luo, Q., Xiao, Y., Alex, A., Cummins, T., & Bhatwadekar, A. D. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26045 · Cited by 19
Gene expression in the pathophysiology of type 2 diabetes mellitus
Patti, M. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0020-x · Cited by 20
Self-citationTirsi, A., Bruehl, H., Sweat, V., Tsui, W., Reddy, S., Javier, E., Lee, C. M., & Convit, A. J. (2009) · Ophthalmology · doi:10.1016/j.ophtha.2008.12.046 · Cited by 20
Assessment of Early Markers of Cardiovascular Risk in Polycystic Ovary Syndrome
Alexandraki, K., Eleitho Practice, A., Kandaraki, E., Poulia, K., Piperi, C., Papadimitriou, E., & Papaioannou, T. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.1.37 · Cited by 19
Fang, F., Gao, Y., Wang, T., Chen, D., Liu, J., Qian, W., Cheng, J., Gao, R., Wang, J., & Xiao, H. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2016.01.007 · Cited by 19
Murdolo, G., Sjöstrand, M., Strindberg, L., Guðbjörnsdóttir, S., Lind, L., Lönnroth, P., & Jansson, P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2737 · Cited by 19
Agarwal, C., Cohen, H. W., Muzumdar, R. H., Heptulla, R. A., Renukuntla, V. S., & Crandall, J. P. (2013) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2013-18 · Cited by 19
The neuropilin-like protein ESDN regulates insulin signaling and sensitivity
Li, X., Jung, J., Nie, L., Razavian, M., Zhang, J., Samuel, V. T., & Sadeghi, M. M. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00782.2015 · Cited by 19
Nadeau, K. J., Ehlers, L. B., Aguirre, L. E., Reusch, J. E. B., & Draznin, B. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00696.x · Cited by 19
Ceolotto, G., Gallo, A., Sartori, M., Valente, R., Baritono, E., Semplicini, A., & Avogaro, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1301 · Cited by 19
Insulin Resistance and Endothelial Dysfunction in Atherosclerosis: Implications and Interventions
Dandona, P. (2002) · Diabetes Technology & Therapeutics · doi:10.1089/152091502321118829 · Cited by 19
Protopsaltis, I. D., Foussas, S. G., Angelidi, A. M., Gritzapis, A. D., Sergentanis, T. Ν., Matsagos, S., Tzirogiannis, K. N., Panoutsopoulos, G. I., Dimitriadis, G., Raptis, S., et al. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-141 · Cited by 18
Autoregulation of insulin receptor signaling through MFGE8 and the αvβ5 integrin
Datta, R., Lizama, C. O., Soltani, A. K., McKleroy, W., Podolsky, M. J., Yang, C. D., Huynh, T. L., Cautivo, K. M., Wang, B., Koliwad, S. K., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2102171118 · Cited by 18
Insulin stimulates arterial neointima formation in normal rats after balloon injury
Foster, E. A., Zhang, S., & Kahn, A. M. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00513.x · Cited by 18
Profiling of human myotubes reveals an intrinsic proteomic signature associated with type 2 diabetes
Al‐Khalili, L., Barbosa, T. D. C., Östling, J., Massart, J., Katayama, M., Nyström, A., Oscarsson, J., & Zierath, J. R. (2013) · Translational Proteomics · doi:10.1016/j.trprot.2013.12.002 · Cited by 18
Bouzakri, K., Roques, M., Debard, C., Berbe, V., Rieusset, J., Laville, M., & Vidal, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1428-1 · Cited by 18
Pandolfi, A., Solini, A., Pellegrini, G., Mincione, G., Silvestre, S. D., Chiozzi, P., Giardinelli, A., Marcantonio, M. C. D., Piccirelli, A., Capani, F., et al. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000185831.13559.a2 · Cited by 18
New developments in type 2 diabetes mellitus: Combination therapy with a thiazolidinedione
Braunstein, S. N. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80195-9 · Cited by 18
Kasımay, Ö., Ergen, N., Bilsel, S., Kaçar, Ö., Deyneli, O., Yavuz, D. G., Akalın, S., Yeğen, B. Ç., & Kurtel, H. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.001 · Cited by 17
Liu, X., Liu, W., Ding, C., Zhao, Y., Chen, X., Khatoon, S., Zheng, Y., Cheng, Z., & Xi, G. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3707904 · Cited by 17
Ho, C. K., Rahib, L., Liao, J. C., Sriram, G., & Dipple, K. M. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.11.003 · Cited by 17
Erol, A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1211 · Cited by 17
Wang, T., Zuo, G., Yao, L., Yuan, C., Li, H., Lai, Y., Chen, Z., Zhang, J., Jin, Y., Yamahara, J., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10901 · Cited by 18
Key signalling pathways underlying the aetiology of polycystic ovary syndrome
Walters, K. A., Moreno-Asso, A., Stepto, N. K., Pankhurst, M. W., Paris, V. R., & Rodgers, R. J. (2022) · Journal of Endocrinology · doi:10.1530/joe-22-0059 · Cited by 19
Insulin increases sensory nerve density and reflex bronchoconstriction in obese mice
Calco, G. N., Maung, J. N., Jacoby, D. B., Fryer, A. D., & Nie, Z. (2022) · JCI Insight · doi:10.1172/jci.insight.161898 · Cited by 18
Yu, Y., Li, W., Xu, L., & Wang, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1124353 · Cited by 16
Bril, F., & Elbert, A. E. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156066 · Cited by 17
Friedrichsen, M. H., Poulsen, P., Richter, E. A., Hansen, B. F., Birk, J. B., Ribel‐Madsen, R., Stender-Petersen, K. L., Nilsson, E., Beck‐Nielsen, H., Vaag, A. A., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1795-8 · Cited by 16
Diabetes Pharmacotherapy in 2012: Considerations in Medication Selection
Cornell, S. A., & Dorsey, V. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.07.2571 · Cited by 16
Metabolic effects of muraglitazar in type 2 diabetic subjects
Fernandez, M., Gastaldelli, A., Triplitt, C. L., Hardies, J., Casolaro, A., Petz, R., Tantiwong, P., Musi, N., Cersósimo, E., Ferrannini, E., et al. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01429.x · Cited by 16
Self-citationJia, X., Huang, J., Huang, X., Li, X., Huang, M., Zhu, H., Li, G.-P., Lan, M.-L., Yu, Z., Xu, W., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8857687 · Cited by 16
Impaired PI3 K Akt expression in liver and skeletal muscle of ovariectomized rats
Wang, Y., Li, B., Zhang, W., Liu, Y., Xue, P., Ma, J., & Li, Y. (2013) · Endocrine · doi:10.1007/s12020-013-9894-1 · Cited by 16
Khan, S. I., Khan, S., Imran, M., Pillai, K. K., Akhtar, M., & Najmi, A. K. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.764991 · Cited by 16
Yang, S.-C., Chen, C., Liao, Y., Lin, F.-C., Lee, W.-C., Cho, Y.-M., Chen, M.-T., Chous, C.-H., & Kuo, C. (2005) · PubMed · Cited by 16
Phoswa, W. N. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.613930 · Cited by 15
Parveen, S., Khan, S., Ahsan, H., Manger, P. T., Gupta, B., & Alam, R. (2022) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2022.200174 · Cited by 17
Kou, C., Cao, X.-G., Qin, D., Ji, C., Zhu, J., Zhang, C., Zhu, C., Gao, C., Chen, R., Guo, X., et al. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0649-5 · Cited by 15
Keen, J., McGorum, B. C., Hillier, C., & Nally, J. E. (2012) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2012.01429.x · Cited by 15
Chang, E., Choi, J. M., Park, S. E., Rhee, E., Lee, W., Oh, K.-W., Park, S., & Park, C. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.02.013 · Cited by 15
Kim, D., Ahn, B., Kim, Y. S., Hur, D. Y., Yang, J. W., Park, G. B., Jang, J. E., Lee, E. J., Kwon, M. J., Kim, T. N., et al. (2019) · Journal of Diabetes Research · doi:10.1155/2019/2376512 · Cited by 15
Chen, T., Chen, S., Wang, D., & Hung, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29021 · Cited by 15
Insulin resistance and the role of gamma-aminobutyric acid
Rezazadeh, H., Sharifi, M., & Soltani, N. (2021) · Journal of Research in Medical Sciences · doi:10.4103/jrms.jrms_374_20 · Cited by 16
The Epidemic of Type 2 Diabetes Mellitus: Its Links to Obesity, Insulin Resistance, and Lipotoxicity
Cusi, K. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_1 · Cited by 15
Self-citationSkin fibroblasts as a tool for identifying the risk of nephropathy in the type 1 diabetic population
Millioni, R., Puricelli, L., Iori, E., Trevisan, R., & Tessari, P. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1287 · Cited by 15
Management of diabetes in dialysis patients
Williams, M. E. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0076-8 · Cited by 15
Physical Activity and Risk of Colon Cancer in Diabetic and Nondiabetic US Adults
Schmid, D., Behrens, G., Matthews, C. E., & Leitzmann, M. F. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.08.017 · Cited by 15
Twarock, S., Reichert, C., Peters, U., Gorski, D. J., Roeck, K., & Fischer, J. W. (2017) · International Journal of Cancer · doi:10.1002/ijc.30776 · Cited by 15
Pathogenesis of Type 2 Diabetes Mellitus
Durruty, P., Sanzana, M. G., & Sanhueza, L. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.83692 · Cited by 15
Dimova, R. B., Tankova, T. I., Кirilov, G., Chakarova, N. Y., Grozeva, G. G., & Dakovska, L. N. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0972-1302 · Cited by 16
Berenguer, A., Mainar, V., Bordes, P., Valencia, J., & Gómez, S. (2006) · Revista Española de Cardiología · doi:10.1157/13084638 · Cited by 15
WANG, C., Sharma, G. D., & Draznin, B. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.10.014 · Cited by 15
Polycystic Ovary Syndrome and Obesity
Barber, T. M., Dimitriadis, G. K., & Franks, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-19821-7_15 · Cited by 15
Metabolic and Molecular Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A., Mandarino, L. J., & Ferrannini, E. (2003) · Wiley eBooks · doi:10.1002/0470862092.d0310 · Cited by 15
Self-citationKarlsson, H., Kasahara, A., Ikeda, M., Chibalin, A., Harada, J., Rydén, M., Krook, A., Kato, M., Kubota, K., & Zierath, J. R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154726 · Cited by 14
Runx2 Regulates the Gene Network Associated with Insulin Signaling and Energy Homeostasis
Adhami, M., Ghori-Javed, F. Y., Chen, H., Gutierrez, S. E., & Javed, A. (2011) · Cells Tissues Organs · doi:10.1159/000324763 · Cited by 13
Amor, S., Martín-Carro, B., Rubio, C., Carrascosa, J. M., Hu, W., Huang, Y., Garcı́a-Villalón, Á. L., & Granado, M. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.10.017 · Cited by 14
Stokes, S. M., Bertin, F., Stefanovski, D., Belknap, J. K., Medina‐Torres, C. E., Pollitt, C. C., & Eps, A. W. V. (2019) · Equine Veterinary Journal · doi:10.1111/evj.13224 · Cited by 14
Mata-Torres, G., Andrade‐Cetto, A., & Espinoza-Hernández, F. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.809994 · Cited by 16
Cersósimo, E., Xu, X., Upala, S., Triplitt, C. L., & Musi, N. (2014) · Physiological Reports · doi:10.14814/phy2.12123 · Cited by 14
Orotic Acid Induces Hypertension Associated with Impaired Endothelial Nitric Oxide Synthesis
Choi, Y., Yoon, Y., Lee, K.-Y., Kang, Y.-P., Lim, D. K., Kwon, S. W., Kang, K.-W., Lee, S.-M., & Lee, B. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv003 · Cited by 14
Adrenoceptor regulation of the mechanistic target of rapamycin in muscle and adipose tissue
Chia, L. Y., Evans, B. A., Mukaida, S., Bengtsson, T., Hutchinson, D. S., & Sato, M. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14616 · Cited by 14
Pathogenesis of Type 2 Diabetes Mellitus
DeFronzo, R. A. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_8 · Cited by 14
Self-citationInsulin Resistance Does Not Influence Gene Expression in Skeletal Muscle
Nguyen, L. L., Kriketos, A. D., Hancock, D., Caterson, I. D., & Denyer, G. S. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.4.457 · Cited by 14
Lee, S. J., Ways, J. A., Barbato, J. C., Essig, D. A., Pettee, K. M., DeRaedt, S. J., Yang, S., Weaver, D. A., Koch, L. G., & Cicila, G. T. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00251.2004 · Cited by 14
Fatty Acids, Insulin Resistance, and Protein Metabolism
Kalhan, S. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1235 · Cited by 14
Pathogenesis of type 2 diabetes mellitus
DeFronzo, R. A. (2015) · Wiley eBooks · doi:10.1002/9781118387658.ch25 · Cited by 17
Self-citationThe Neglected Role of Bile Duct Epithelial Cells in NASH
Cadamuro, M., Lasagni, A., Sarcognato, S., Guido, M., Fabris, R., Strazzabosco, M., Strain, A. J., Simioni, P., Villa, E., & Fabris, L. (2021) · Seminars in Liver Disease · doi:10.1055/s-0041-1739455 · Cited by 13
Mann, G., Riddell, M. C., & Adegoke, O. A. J. (2022) · Diabetology · doi:10.3390/diabetology3030032 · Cited by 16
Ryan, A. S., Li, G., McMillin, S. L., Prior, S. J., Blumenthal, J. B., & Mastella, L. (2021) · Cells · doi:10.3390/cells10123490 · Cited by 13
Molecular Mechanisms of Insulin Resistance
Draznin, B. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_4 · Cited by 13
Huo, Y., Ji, S., Yang, H. J., Wu, W., Yu, L., Ren, Y., & Wang, F. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-2941 · Cited by 13
Metadata
- Authors
- Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., & Mandarino, L. J.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Harvard University (US)
- Tulane University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Mandarino, Lawrence J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2000-02-01
- Volume
- 105
- Issue
- 3
- Pages
- 311-320
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC377440
- OpenAlex
- W2120852510
- Cited by
- 1,139
- References
- 48
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 19 · 2023: 27 · 2022: 35 · 2021: 45 · 2020: 33 · 2019: 35 · 2018: 24 · 2017: 37 · 2016: 52 · 2015: 54 · 2014: 53 · 2013: 57 · 2012: 65
- FWCI
- 13.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5k08dk002526-03)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK-24092, DK02526, R01DK047936, R01DK033201, R01DK024092, R01-DK-47936)
- National Center for Research Resources (M01RR001346)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- insulin resistance, skeletal muscle, type 2 diabetes, PI3K signaling, MAPK signaling, insulin receptor, IRS-1, p85 regulatory subunit, physical activity, glucose uptake, obesity, euglycemic clamp, insulin signaling
- MeSH terms
- Adult, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Phosphoproteins, Receptor, Insulin, Signal Transduction, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinases, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
